Clinical Trial: A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07221838) titled 'A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab' on Oct. 03.

Brief Summary: This is a prospective, multicenter single arm study designed to evaluate the effectiveness and safety of a predefined oral corticosteroids (OCS) tapering schedule to reduce OCS use in adult participants with acetylcholine receptor positive (AChR+) generalized myasthenia gravis (gMG) being treated with intravenous ravulizumab.

Study Start Date: Dec. 31

Study Type: INTERVENTIONAL

Condition: Generalized Myasthenia Gravis gMG

Intervention: PROCEDURE: Oral Corticosteroid Tapering Schedule...